Clinical Trials Browser

Has results × Ramucirumab × 30 days × Clear all

NCT04632459 2026-06-05

Pembrolizumab Plus Ramucirumab in Metastatic Gastric Cancer

Phase 2 Completed

26 enrolled 9 charts

Gastrointestinal

Stomach Neoplasms